Inspire Medical Systems (INSP) Could Be 10% Overvalued After Its 90 Day Rebound

Inspire Medical Systems (INSP) drew attention after its recent share move, with the price closing at US$68.10. Investors are weighing this level against the stock’s recent swings and its current implied valuation.

Recent trading tells a mixed story. The share price return over the past 90 days is up 30.41%, yet the year to date share price return is down 26.19% and the 3 year total shareholder return has declined 59.87%. This points to improving short term momentum against a weaker long term record.

Scan how Inspire Medical Systems compares to other health-focused opportunities by reviewing a curated set of 34 healthcare AI stocks that are already catching investor attention.

After a sharp 90 day rebound yet heavy multi year damage, Inspire Medical Systems now sits close to its stated price target. Does the balance of risk and potential reward still lean toward buyers or toward caution?

Most Popular Narrative: 10% Overvalued

Against the last close at $68.10, the most followed narrative pegs Inspire Medical Systems at a fair value of $68.00, which implies the stock trades roughly 10% rich to that framework once the discounting assumptions are factored in.

The view that Inspire Medical Systems is fairly valued and bearish implies that the current share price already reflects expectations for improving margins, reimbursement clarity, and long-term OSA market penetration. This leaves limited room for upside if execution simply matches current guidance.

See why 10 investors see Inspire Medical Systems as 0% overvalued.

Result: Fair Value of $68.00 (OVERVALUED)

Still, the narrative around Inspire Medical Systems could be knocked off course if WISeR related disruptions drag out or legal scrutiny around the Inspire V launch escalates.

Find out about the key risks to this Inspire Medical Systems narrative.

Another View: Inspire Medical Systems Through The Earnings Lens

There is a twist when shifting from that fair value of $68.00 to what the market is actually paying for Inspire Medical Systems today. At a P/E of 14.6x, the stock trades well below the US Medical Equipment group on 23.8x and under the estimated fair ratio of 21.2x. This points to a meaningful valuation gap that could either reflect genuine execution risk or leave room for sentiment to reset if the story improves.

For a closer look at how this earnings based view is constructed and where the fair ratio might matter most for risk, see See what the numbers say about this price — find out in our valuation breakdown..

Next Steps

Mixed messages on Inspire Medical Systems so far. If the crosscurrents feel strong, move quickly and review the data yourself, including the 3 key rewards and 1 important warning sign.

Looking for more investment ideas beyond Inspire Medical Systems?

If Inspire Medical Systems has you thinking harder about price and risk, do not stop there. Put a broader watchlist to work using focused stock screens.

• Target potential mispricings by reviewing a curated 33 high quality undervalued stocks that line up strong fundamentals with prices the market may not fully appreciate yet.
• Shield your portfolio from fragile balance sheets by filtering for a list of solid balance sheet and fundamentals (24 results) that can better withstand tough operating conditions.
• Get ahead of the crowd by scanning a focused set of 19 high quality undiscovered gems that combine quality metrics with relatively low current attention.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com